A new Ohio University study offers a glimmer of hope in the fight against lung cancer. Monica Robins has that story and more in Tuesday's Daily Dose.

A team of scientists from the United Kingdom has developed a new blood test that could change the way lung cancer is detected and monitored. A new study talks about using the Fourier Transform ...

A state-led AI screening drive flags hidden tumours early and sparks national scale-up talks ...

The U.S. Food and Drug Administration (FDA) has approved Hernexeos (zongertinib) for adults with unresectable or metastatic non-squamous non-small cell lung cancer whose tumors have specific HER2 ...

WASHINGTON, Jan. 15, 2026 /PRNewswire/ -- LUNGevity Foundation, the nation's leading lung cancer--focused nonprofit organization, is now accepting applications for their 2026 research grants. These ...

The American Cancer Society’s Cancer Statistics, 2026 report highlights a historic milestone: the 5-year relative survival rate for all cancers combined has reached 70%, up from 49% in the mid-1970s.

(Nanowerk News) In a major step forward for cancer care, researchers at ChristianaCare’s Gene Editing Institute have shown that disabling the NRF2 gene with CRISPR technology can reverse chemotherapy ...

MAIA’s 2026 Letter to Shareholders is available in its entirety at ir.maiabiotech.com.

A new Ohio University study offers a glimmer of hope in the fight against lung cancer. Monica Robins has that story and more ...